MedKoo Cat#: 464586 | Name: UMB298
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

UMB298 is a Potent and Selective CBP/P300 Inhibitor with CBP IC50 72 nM and bromodomain 4, BRD4 IC50 5193 nM. UMB298 inhibited MOLM13 cells growth. Moreover, UMB298 reduced the H3K27ac level similar to CBP30 and caused MYC depletion as a signature of CBP inhibition in acute myeloid leukemia. Certainly, the results suggest that UMB298 has excellent anti-cancer effect. Not only that, UMB298 displayed 72-fold selectivity for CBP over BRD4 as a selective CBP inhibitor.

Chemical Structure

UMB298
UMB298
CAS#2266569-73-5

Theoretical Analysis

MedKoo Cat#: 464586

Name: UMB298

CAS#: 2266569-73-5

Chemical Formula: C27H31ClN4O2

Exact Mass: 478.2136

Molecular Weight: 479.02

Elemental Analysis: C, 67.70; H, 6.52; Cl, 7.40; N, 11.70; O, 6.68

Price and Availability

Size Price Availability Quantity
25mg USD 550.00 2 Weeks
50mg USD 950.00 2 Weeks
100mg USD 1,650.00 2 Weeks
200mg USD 2,650.00 2 Weeks
500mg USD 4,250.00 2 Weeks
1g USD 5,850.00 2 Weeks
2g USD 9,950.00 2 Weeks
Show More
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
UMB298; UMB-298; UMB 298;
IUPAC/Chemical Name
2-(3-chloro-4-methoxyphenethyl)-N-cyclohexyl-7-(3,5-dimethylisoxazol-4-yl)imidazo[1,2-a]pyridin-3-amine
InChi Key
NZXSWCLCRDCHGN-UHFFFAOYSA-N
InChi Code
InChI=1S/C27H31ClN4O2/c1-17-26(18(2)34-31-17)20-13-14-32-25(16-20)30-23(27(32)29-21-7-5-4-6-8-21)11-9-19-10-12-24(33-3)22(28)15-19/h10,12-16,21,29H,4-9,11H2,1-3H3
SMILES Code
ClC1=CC(CCC2=C(NC3CCCCC3)N4C(C=C(C5=C(C)ON=C5C)C=C4)=N2)=CC=C1OC
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
The use of epigenetic bromodomain inhibitors as anticancer therapeutics has transitioned from targeting bromodomain extraterminal domain (BET) proteins into targeting non-BET bromodomains. The two most relevant non-BET bromodomain oncology targets are cyclic AMP response element-binding protein (CBP) and E1A binding protein P300 (EP300).

Preparing Stock Solutions

The following data is based on the product molecular weight 479.02 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Muthengi A, Wimalasena VK, Yosief HO, Bikowitz MJ, Sigua LH, Wang T, Li D, Gaieb Z, Dhawan G, Liu S, Erickson J, Amaro RE, Schönbrunn E, Qi J, Zhang W. Development of Dimethylisoxazole-Attached Imidazo[1,2-a]pyridines as Potent and Selective CBP/P300 Inhibitors. J Med Chem. 2021 Apr 19. doi: 10.1021/acs.jmedchem.0c02232. Epub ahead of print. PMID: 33872011.